Cargando…
S6K in geroconversion
Markers of cellular senescence depend in part on the MTOR (mechanistic target of rapamycin) pathway. MTOR participates in geroconversion, a conversion from reversible cell cycle arrest to irreversible senescence. Recently we demonstrated that hyper-induction of cyclin D1 during geroconversion was mo...
Autores principales: | Leontieva, Olga V, Demidenko, Zoya N, Blagosklonny, Mikhail V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885635/ https://www.ncbi.nlm.nih.gov/pubmed/24036549 http://dx.doi.org/10.4161/cc.26248 |
Ejemplares similares
-
Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program)
por: Leontieva, Olga V., et al.
Publicado: (2015) -
Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion
por: Leontieva, Olga V., et al.
Publicado: (2014) -
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: Duration of cell cycle arrest and MTOR activity determine geroconversion
por: Leontieva, Olga V, et al.
Publicado: (2013) -
Rapamycin, proliferation and geroconversion to senescence
por: Blagosklonny, Mikhail V.
Publicado: (2018) -
Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells
por: Leontieva, Olga V., et al.
Publicado: (2012)